GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3576 - 3600 of 4050 in total
Antibody Patient Onset (days) Symptom ▼ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgM Patient 3 4 mild
G41200QS
87
IgM Patient 3 4 mild
G42346AP
13720
IgM Patient 3 4 mild
G42666HT
1284
IgM Patient 3 4 mild
G43534QA
688
IgM Patient 3 4 mild
G43648DB
5607
IgM Patient 3 4 mild
G47362BJ
1637
IgM Patient 3 4 mild
G47548GA
122
IgM Patient 3 4 mild
G47566FL
68
IgM Patient 3 4 mild
G48898TH
259
IgM Patient 3 4 mild
G49108TO
12026
IgM Patient 3 4 mild
G49916XD
1024
IgM Patient 3 4 mild
G51175PR
5287
IgM Patient 3 4 mild
G51872EK
115
IgM Patient 3 4 mild
G52880ZN
87
IgM Patient 3 4 mild
G53168IY
131
IgM Patient 3 4 mild
G54064FW
207
IgM Patient 3 4 mild
G57449OF
95
IgM Patient 3 4 mild
G58547FH
148
IgM Patient 3 4 mild
G58969RU
105
IgM Patient 3 4 mild
G60761LT
11966
IgM Patient 3 4 mild
G61399NC
171
IgM Patient 3 4 mild
G61751GZ
100
IgM Patient 3 4 mild
G62222PE
8685
IgM Patient 3 4 mild
G62826CL
113
IgM Patient 3 4 mild
G63074CQ
131

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024